Supplementary Figure S1 from Acquired High Tumor Mutational Burden and Activity of Immunotherapy after Targeted Therapy in Microsatellite Stable Colorectal Cancer

2026 Open access

Read full text
Authors: Celine Yeh, Oliver Artz, Haochen Zhang, Elias-Ramzey R. Karnoub, Peter Ntiamoah, Caroline M. Weipert, Henry S. Walch, Emily C. Harrold, Fergus Keane, Sree Bhavani Chalasani, Neil Howard Segal, Michael Bonner Foote
+8 more Andrea Cercek, Andrew Pagano, Steven Brad Maron, Luis Alberto Diaz, Christine A. Iacobuzio–Donahue, Jinru Shia, Benoît Rousseau, Rona D. Yaeger
DOI: 10.1158/1078-0432.31744586
Cited by: 0

Abstract

Comparisons of genomic characteristics in patient tumors that acquired versus did not acquire high TMB after targeted therapy

Fields of Study & Subjects

Colorectal Cancer Treatments and Studies Cancer Immunotherapy and Biomarkers Genetic factors in colorectal cancer

Publication details

Publication date
16 March 2026
Language
EN